SOLID CANCERS
Clinical trials for SOLID CANCERS explained in plain language.
Never miss a new study
Get alerted when new SOLID CANCERS trials appear
Sign up with your email to follow new studies for SOLID CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study tests a special radiation method called lattice radiation therapy (LRT) combined with immunotherapy for people with advanced solid tumors that have stopped responding to standard treatments. LRT delivers high doses of radiation to specific spots inside the tumor while …
Matched conditions: SOLID CANCERS
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 17, 2026 05:36 UTC
-
Experimental 'Armored' cell shot targets solid cancers in tiny safety trial
Disease control Recruiting nowThis early study is testing a single injection of special immune cells (dendritic cells) that are 'armored' with antibodies to see if they are safe for people with solid tumors like pancreatic, colorectal, or stomach cancer. Only 8 adults who have already had surgery and chemothe…
Matched conditions: SOLID CANCERS
Phase: PHASE1 • Sponsor: Shanghai Cell Therapy Group Co.,Ltd • Aim: Disease control
Last updated May 17, 2026 05:34 UTC
-
New drug cocktail shows promise for tough cancers
Disease control Recruiting nowThis study tests a new drug called TCC1727 combined with other cancer treatments (benmelstobart, olaparib, or topotecan) for people with advanced solid tumors that have stopped responding to standard therapy. The goal is to find the safest dose and see if the combination can shri…
Matched conditions: SOLID CANCERS
Phase: PHASE1, PHASE2 • Sponsor: Beijing Tide Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 17, 2026 05:28 UTC
-
Engineered immune cells take on Hard-to-Treat solid tumors
Disease control Recruiting nowThis early-phase study tests a new treatment called Anti-CEA CAR-T for people with advanced solid tumors (like colorectal or stomach cancer) that have not responded to standard therapies. The treatment uses a patient's own immune cells, modified in a lab to target a protein calle…
Matched conditions: SOLID CANCERS
Phase: PHASE1 • Sponsor: Weijia Fang, MD • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New drug targets tough cancers with rare gene mutation
Disease control Recruiting nowThis study tests a drug called tunlametinib in 15 adults with advanced solid tumors that have a specific change in the NRAS gene and have not responded to other treatments. The goal is to see if the drug can shrink tumors or slow their growth. Participants will take the drug by m…
Matched conditions: SOLID CANCERS
Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC
-
Scientists track immune clues to improve cancer treatment
Knowledge-focused Recruiting nowThis study aims to find biological markers in blood and tumor samples that can predict how well immunotherapy works and what side effects may occur. It will enroll 770 adults with advanced solid cancers like lung, head and neck, melanoma, or bladder cancer who are receiving immun…
Matched conditions: SOLID CANCERS
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated May 17, 2026 05:29 UTC
-
Florida cancer study aims to speed up personalized treatment plans
Knowledge-focused Recruiting nowThis study is testing whether a new lab platform can quickly suggest personalized cancer treatments for 210 patients in Florida whose cancer has come back or not responded to standard therapy. The platform combines drug sensitivity testing and genetic profiling to recommend optio…
Matched conditions: SOLID CANCERS
Phase: NA • Sponsor: First Ascent Biomedical Inc. • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC